Tendarix.ca
BUSINESS NEWS
Storm Clouds Continue to Gather Over Canada’s Economy· EnergyNowOpinion: Mark Carney’s climate ambitions still threaten Canada’s economy· Financial PostQ3-26 Canadian Business Outlook Survey: More firms plan cost pass-through· RBCA new chapter in Canada-India economic relations· Business Council of CanadaStaying in Canada is a 'huge relief' for Alberta business leaders· CBCTrump administration cancels some Canada tariffs amid close midterm races· NBC NewsWhat Canadian Businesses Must Embrace to Compete in a Volatile Global Economy· Open CanadaCarney, Erdogan launch ‘strong and resilient’ Canada-Turkiye partnership· Al JazeeraJapan-Canada Chambers Council Joint Statement· Canadian Chamber of CommerceGlobal trade is changing how the Canadian economy works· Bank of CanadaEastern Canada business leaders call for ‘single economy’ between Atlantic provinces· Global NewsSoft economy should limit Bank of Canada's rate hikes: Capital Economics· BNN BloombergCanada’s services PMI shows sector shrinking for fourth straight month in September· The Globe and MailCanada’s inflation data, business survey on tap ahead of BoC decision· RBCPosthaste: U.S. businesses feel fresh pain from trade war with Canada, says this hot take on the economy· Financial Post
← All tenders
Public Works and Government Services Canada

Vaccin contre la variole - 2ème génération

Advance Contract Award Notice (ACAN)
Estimated value
Not disclosed
Deadline
January 11, 2021
Published
December 24, 2020
Type
Goods
Explore similarQuebec

Full description

Trade Agreement: Canadian Free Trade Agreement (CFTA)
Tendering Procedures: Generally only one firm has been invited to bid
Non-Competitive Procurement Strategy: Exclusive Rights
Comprehensive Land Claim Agreement: No
Vendor Name and Address:
EMERGENT BIOSOLUTIONS CANADA INC.
155 Innovation Drive
Winnipeg Manitoba
Canada
R3T5Y3
Nature of Requirements:

Purpose of ACAN:

Public Services and Procurement Canada proposes to negotiate a contract with Emergent BioSolutions Inc. on behalf of the Public Health Agency of Canada (PHAC) for the purchase of ACAM2000®.

Definition of Requirement:

ACAM2000® is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. Although smallpox disease is currently considered to be eradicated, PHAC is procuring a stockpile of the vaccine to immunize Canadians against smallpox disease should a risk ever arise where smallpox is intentionally or unintentionally released.

Quantities:

The estimated quantity for the firm delivery is 5,800 vials (580,000 treatment courses), with 4,600 vials (460,000 treatment courses) in optional quantities.

Term of Contract:

Contract award to March 31, 2024.

Evaluation Criteria:

1) The vaccine must have current regulatory approval by one of the following organizations: Health Canada (HC), the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), or the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA).

2) The vaccine must be approved by HC or the US FDA or EMA or UK MHRA with an indication for active immunization against smallpox disease.

3) The vaccine must be supplied in multiple-dose glass vials containing lyophilized powder (freeze-dried vaccine). At a storage temperature of -15°C to -25°C, the vaccine must have a minimum of sixteen (16) years of shelf life from the date of manufacture of the final product.

4) The Vendor must supply the initial requirement of 1,800 vials with a delivery date no later than March 31, 2021, with at least 16 years of shelf life.

5) The vaccine must be supplied with the required amount of diluent, bifurcated needles and tuberculin syringes for the initial deliveries as well as the required amount to replace up to 1,040,000 treatment courses for duration of the vaccine 16 year shelf life.

Delivery:

1,800 vials on or before March 31, 2021;
2,000 vials on or before March 31, 2022; and
2,000 vials on or before March 31, 2023.

As and when required for the optional quantities.

Limited Tendering Reason:

In accordance with Government Contract Regulations (GCRs Part 1 - Conditions of Contract Entry - Bids - 6.(d)) Emergent BioSolutions Inc., is the only known supplier of a 2nd generation smallpox vaccine approved with either HC, the FDA, EMA, or MHRA for the treatment of human smallpox disease.

Delivery Date: Above-mentioned

You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above.

An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process.

Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements.

The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page.

The Crown retains the right to negotiate with suppliers on any procurement.

Documents may be submitted in either official language of Canada.

Intended sole-source award

The buyer plans to award this contract to a named supplier without competition. If your business can do this work, send a statement of capabilities to the contracting authority before January 11, 2021. If it qualifies, the buyer must open a full competition.

AI Analysis

Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.

Basic information

Reference
PW-__PH-893-79510
Solicitation no.
6D024-203934/A
Buyer
Public Works and Government Services Canada
Notice type
Advance Contract Award Notice
Method
Non-competitive
Procurement category
*GD
Trade agreements
*Canadian Free Trade Agreement (CFTA)
Estimated value
Not disclosed
Source
canadabuys

Classification & terms

GSIN
*N6505 — *Drugs and Biologicals

Delivery & regions

Province
Quebec
Regions of delivery
*National Capital Region (NCR)

Key dates

Published
December 24, 2020
Closes
January 11, 2021
Amendment no.
000

Contact

End-user
Public Health Agency of Canada
Sign up free to see the contact details

Award history

4 past awards in this classification and 0 likely incumbents from this buyer. Pro shows who won and for how much.

Upgrade to Pro

Live tenders

Royal Canadian Navy (RCN)Closing today

Furniture Installation

Indigenous set-asideGoods
75 MATCHView →
Department of National Defence (DND)1 day left

4 X Winter Loaders Rental

Services
78 MATCHView →
Department of Public Works and Government Services (PSPC)1 day left

Solicitation of Offers – FR-EN Translation Services - General and Administrative Texts Field- Tier 2

Services
79 MATCHView →